1. Home
  2. GCTK vs WLGS Comparison

GCTK vs WLGS Comparison

Compare GCTK & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • WLGS
  • Stock Information
  • Founded
  • GCTK 2001
  • WLGS 1981
  • Country
  • GCTK United States
  • WLGS Hong Kong
  • Employees
  • GCTK N/A
  • WLGS N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • WLGS Engineering & Construction
  • Sector
  • GCTK Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • GCTK Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • GCTK 3.7M
  • WLGS 4.4M
  • IPO Year
  • GCTK N/A
  • WLGS 2023
  • Fundamental
  • Price
  • GCTK $5.60
  • WLGS $0.04
  • Analyst Decision
  • GCTK
  • WLGS
  • Analyst Count
  • GCTK 0
  • WLGS 0
  • Target Price
  • GCTK N/A
  • WLGS N/A
  • AVG Volume (30 Days)
  • GCTK 1.6M
  • WLGS 66.9M
  • Earning Date
  • GCTK 08-12-2025
  • WLGS 08-14-2025
  • Dividend Yield
  • GCTK N/A
  • WLGS N/A
  • EPS Growth
  • GCTK N/A
  • WLGS N/A
  • EPS
  • GCTK N/A
  • WLGS N/A
  • Revenue
  • GCTK N/A
  • WLGS $3,951,649.00
  • Revenue This Year
  • GCTK N/A
  • WLGS N/A
  • Revenue Next Year
  • GCTK N/A
  • WLGS N/A
  • P/E Ratio
  • GCTK N/A
  • WLGS N/A
  • Revenue Growth
  • GCTK N/A
  • WLGS N/A
  • 52 Week Low
  • GCTK $5.16
  • WLGS $0.03
  • 52 Week High
  • GCTK $3,756.00
  • WLGS $9.66
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 40.61
  • WLGS 32.09
  • Support Level
  • GCTK $5.61
  • WLGS $0.04
  • Resistance Level
  • GCTK $7.38
  • WLGS $0.08
  • Average True Range (ATR)
  • GCTK 1.25
  • WLGS 0.01
  • MACD
  • GCTK 0.04
  • WLGS 0.01
  • Stochastic Oscillator
  • GCTK 4.40
  • WLGS 27.27

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.

Share on Social Networks: